Keyphrases
Taiwan
100%
Endometriosis
83%
Induced Pluripotent Stem Cells (iPSCs)
79%
Confidence Interval
64%
Taiwanese
64%
Adenomyosis
61%
Epithelial Ovarian Cancer
58%
Estrogen
55%
Retrospective Cohort Study
47%
Endometrial Cancer
42%
Myomectomy
41%
Postmenopausal Women
40%
Ovarian Cancer
40%
Uterine Sarcoma
39%
Laparoscopic Surgery
39%
Overall Survival
37%
Gonadotropin-releasing Hormone
36%
Cervical Cancer
36%
Laparoscopic Myomectomy
35%
Ovarian Cancer Patients
32%
Gestational Age
32%
Cisplatin
31%
Angiogenesis
31%
Operative Time
30%
Fallopian Tube Carcinoma
29%
Bipolar Coagulation
29%
Uterine Vessels
29%
Taiwanese Women
29%
Single Port
29%
Rare Case Report
29%
Endometrial Carcinoma
29%
Laparoscopic Cystectomy
29%
Overexpression
29%
Cyclooxygenase-2
28%
Obstetrics
27%
Advanced Stage
26%
Randomized Controlled Trial
26%
Prognostic Factors
26%
Ovarian Clear Cell Carcinoma
24%
Mouse Model
23%
Normal Pregnancy
23%
Agonist Treatment
23%
Hazard Ratio
23%
Transplantation
23%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
23%
Laparoscopy
22%
Single-port Laparoscopic
22%
Older Women
21%
Conventional Laparoscopic
21%
Stress Urinary Incontinence
21%
Myoma
21%
Cyclooxygenase-2 Expression
21%
C-Myc
20%
Hepatoprotective
20%
Liver Injury
19%
Symptomatic Uterine Fibroids
19%
Gynecologic Oncology Group
19%
Cervical Squamous Cell Carcinoma
19%
Invasive Cervical Cancer
19%
Power Doppler Ultrasound
19%
Ultraminilaparotomy
19%
ST6GAL1
19%
Parasitic Myoma
19%
Laparoscopic Morcellation
19%
PRISMA
19%
Ovarian Dermoid Cyst
19%
Endometrial Epithelial Cells
19%
Young Women
19%
Fallopian Tube
19%
Endometrioma Recurrence
19%
Cisplatin-based Chemotherapy
19%
Laparotomy
19%
Sialyltransferase
19%
Upper Abdominal Pain
19%
Gynecological Laparoscopic Surgery
19%
Estrogen Receptor
19%
Transobturator
19%
Laparoscopic Ovarian Drilling
19%
Wound Healing
19%
Mini
19%
Polycystic Ovary Syndrome
19%
Intervention Group
19%
Abdominal Pain
19%
Adverse Events
19%
Disease-free Survival
19%
Paclitaxel
18%
Recurrence Rate
18%
Fibroids
18%
Risk Factors
18%
Ifosfamide
17%
Cervical Tissue
17%
Endometrial Stromal Sarcoma
17%
Clear Cell Type
17%
Carbohydrate Antigen 125 (CA125)
17%
Incidence Rate
16%
Immunohistochemistry
16%
Dysmenorrhea
16%
Odds Ratio
16%
Dienogest
16%
Visual Analog Scale
16%
Medicine and Dentistry
Endometriosis
86%
Krukenberg Tumor
74%
Systematic Review
70%
Uterine Myomectomy
67%
Myoma
66%
Adenomyosis
63%
Ovarian Cancer
60%
Neoplasm
58%
Cervical Cancer
54%
Recurrent Disease
54%
Retrospective Cohort Study
47%
Uterine Cancer
45%
Cisplatin
44%
Diseases
43%
Gestational Age
43%
Overall Survival
42%
Pelvis
41%
Cystectomy
41%
Laparoscopic Surgery
41%
Pregnancy
40%
Uterus Sarcoma
39%
Induced Pluripotent Stem Cell
39%
Operation Duration
35%
Clear Cell Carcinoma
34%
Cyclooxygenase 2
33%
Cancer
33%
Uterine Fibroid
32%
Angiogenesis
31%
Bleeding
30%
Uterine Tube Carcinoma
29%
Morcellation
29%
Stress Incontinence
29%
Endometrium Carcinoma
29%
Adenocarcinoma
29%
Menorrhagia
29%
Obstetrics
28%
Gynecology
28%
Dentigerous Cyst
26%
First Trimester Pregnancy
26%
Prognostic Factor
25%
Randomized Controlled Trial
24%
Surgery
23%
Gonadorelin Agonist
23%
Disease Free Survival
22%
Metastatic Carcinoma
22%
Endometrium
22%
Squamous Cell Carcinoma
22%
Breast Cancer
21%
Mesenchymal-Epithelial Transition
21%
Doppler Flowmetry
21%
Doppler Ultrasound
21%
Carcinoma
21%
Ovarian Tumor
21%
Blood Flow
21%
Echography
20%
Immunohistochemistry
20%
Carcinosarcoma
19%
Gynecological Oncology
19%
Epithelial Cell
19%
Oncogene C Myc
19%
Therapy Effect
19%
Liver Injury
19%
Laparotomy
19%
Polycystic Ovary Syndrome
19%
Protein P53
19%
Hepatocyte
19%
Cytoreductive Surgery
18%
Postmenopause
18%
Adverse Event
18%
Paclitaxel
17%
Ifosfamide
17%
Proportional Hazards Model
16%
Carcinogenesis
16%
Dienogest
16%
Odds Ratio
16%
Cohort Analysis
16%
Hazard Ratio
16%
Cervix
15%
Carbon Dioxide
15%
Hysterectomy
15%
Recurrence Risk
15%
Dysmenorrhea
15%
Programmed Cell Death
15%
Cesarean Section
14%
Assisted Reproductive Technology
14%
Connective Tissue Cancer
14%
Premenopause
14%
Lymphadenopathy
14%
Lymph Node
14%
Lymph Node Metastasis
14%
Salpingooophorectomy
14%
Diagnosis
14%
Visual Analog Scale
14%
Premature Labor
14%
Postoperative Pain
14%
Maintenance Therapy
13%
Observational Study
13%
Vaginal Hysterectomy
13%
Progression Free Survival
13%
Case-Control Study
13%